CLSD

NASDAQ

Clearside Biomedical Inc.

SectorHealth CareIndustryBiotechnology: Pharmaceutical PreparationsIPO2016

News25/Ratings8

Clearside Biomedical, Inc., a biopharmaceutical company, engages in the developing and delivering treatments that restore and preserve vision for people with serious eye diseases. Its product includes CLS-AX, an axitinib for suprachoroidal injection which is in Phase 1/2a clinical trial. It also develops XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of macular edema associated with uveitis, diabetic macular edema, and macular edema associated with retinal vein occlusion. The company was incorporated in 2011 and is headquartered in Alpharetta, Georgia.

News · 26 weeks170%

2025-10-262026-04-19

Mix090d

No activity.

Latest news

25 items

129dSEC
SEC Form S-8 POS filed by Clearside Biomedical Inc.
S-8 POS - Clearside Biomedical, Inc. (0001539029) (Filer)
129dSEC
SEC Form S-8 POS filed by Clearside Biomedical Inc.
S-8 POS - Clearside Biomedical, Inc. (0001539029) (Filer)
129dSEC
SEC Form S-8 POS filed by Clearside Biomedical Inc.
S-8 POS - Clearside Biomedical, Inc. (0001539029) (Filer)
129dSEC
SEC Form S-8 POS filed by Clearside Biomedical Inc.
S-8 POS - Clearside Biomedical, Inc. (0001539029) (Filer)
129dSEC
SEC Form S-8 POS filed by Clearside Biomedical Inc.
S-8 POS - Clearside Biomedical, Inc. (0001539029) (Filer)
129dSEC
SEC Form S-8 POS filed by Clearside Biomedical Inc.
S-8 POS - Clearside Biomedical, Inc. (0001539029) (Filer)
129dSEC
SEC Form S-8 POS filed by Clearside Biomedical Inc.
S-8 POS - Clearside Biomedical, Inc. (0001539029) (Filer)
129dSEC
SEC Form S-8 POS filed by Clearside Biomedical Inc.
S-8 POS - Clearside Biomedical, Inc. (0001539029) (Filer)
129dSEC
SEC Form POS AM filed by Clearside Biomedical Inc.
POS AM - Clearside Biomedical, Inc. (0001539029) (Filer)
129dSEC
SEC Form S-8 POS filed by Clearside Biomedical Inc.
S-8 POS - Clearside Biomedical, Inc. (0001539029) (Filer)
129dSEC
SEC Form S-8 POS filed by Clearside Biomedical Inc.
S-8 POS - Clearside Biomedical, Inc. (0001539029) (Filer)
129dSEC
SEC Form POS AM filed by Clearside Biomedical Inc.
POS AM - Clearside Biomedical, Inc. (0001539029) (Filer)
136dSEC
SEC Form 8-K filed by Clearside Biomedical Inc.
8-K - Clearside Biomedical, Inc. (0001539029) (Filer)
136dSEC
SEC Form 25 filed by Clearside Biomedical Inc.
25 - Clearside Biomedical, Inc. (0001539029) (Filer)
149dSEC
Clearside Biomedical Inc. filed SEC Form 8-K: Regulation FD Disclosure
8-K - Clearside Biomedical, Inc. (0001539029) (Filer)
150dPR
Clearside Biomedical to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
- Intended to Maximize Stakeholder Value Through Structured Process - - Validated SCS Microinjector® Delivery Platform Anchored by Commercial Product and Five Suprachoroidal Licensing Collaborations with Future Royalty Revenue Potential - - CLS-AX TKI Program Includes Phase 3-Ready Asset in Wet AMD and Path for Phase 2b/3 Trial in Diabetic Retinopathy - - IND-Ready Programs Targeting Geographic Atrophy and Diabetic Macula Edema - ALPHARETTA, Ga., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD) ("Clearside" or the "Company"), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (
160dSEC
SEC Form 10-Q filed by Clearside Biomedical Inc.
10-Q - Clearside Biomedical, Inc. (0001539029) (Filer)
198dSEC
Clearside Biomedical Inc. filed SEC Form 8-K: Other Events
8-K - Clearside Biomedical, Inc. (0001539029) (Filer)
224dSEC
Clearside Biomedical Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
8-K - Clearside Biomedical, Inc. (0001539029) (Filer)
224dSEC
Clearside Biomedical Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
8-K - Clearside Biomedical, Inc. (0001539029) (Filer)
227dSEC
Clearside Biomedical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement
8-K - Clearside Biomedical, Inc. (0001539029) (Filer)
232dSEC
Clearside Biomedical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Submission of Matters to a Vote of Security Holders
8-K - Clearside Biomedical, Inc. (0001539029) (Filer)
252dSEC
Clearside Biomedical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Leadership Update
8-K - Clearside Biomedical, Inc. (0001539029) (Filer)
258dSEC
SEC Form 10-Q filed by Clearside Biomedical Inc.
10-Q - Clearside Biomedical, Inc. (0001539029) (Filer)
262dSEC
SEC Form DEF 14A filed by Clearside Biomedical Inc.
DEF 14A - Clearside Biomedical, Inc. (0001539029) (Filer)